Esomeprazole Magnesium
Product Images NDC 76519-1173

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 76519-1173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (76519 1173 Ppac Label)

Label for Esomeprazole Magnesium delayed-release 40 mg capsules, package of 30, labeled by H.J. Harkins Company, Inc. The label includes NDC 76519-1173-03 and references manufacturer DR.REDDY'S with NDC 43598-0510-30. It features a caution about federal law and prescription requirements, dosage instructions to use as directed by physician, and multiple secondary labels with quantity, lot number, and expiration placeholders.*

FDA Label Image

Figure 1 (Figure1)

Chemical structure diagram of Esomeprazole Magnesium Trihydrate showing the molecular arrangement including methoxy, methyl groups, and magnesium ions with water molecules.*

FDA Label Image

Figure 2 (Figure2)

A line chart showing the percentage of subjects maintained over a six-month period for esomeprazole magnesium at doses of 10 mg, 20 mg, 40 mg, and placebo. The x-axis represents months from 0 to 6, and the y-axis represents percent maintained from 0 to 100%. The chart includes four lines each identifying the different dose groups and placebo as indicated in the legend.*

FDA Label Image

Figure 3 (Figure3)

A line chart depicting the percent of maximum response over a 6-month period for Esomeprazole at doses of 40 mg, 20 mg, and 10 mg, compared to a placebo. The x-axis represents months, while the y-axis shows percent maximum. Each treatment group is represented with distinct symbols and lines, showing trends over time.*

FDA Label Image

Figure 4 (Figure4)

A line graph comparing the percent of patients symptom-free over a 28-day period among three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The graph shows symptom improvement trends by day for each treatment group.*

FDA Label Image

Figure 5 (Figure5)

A line chart comparing the percent of patients symptom-free over 28 days among three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents diary days (0 to 28) and the y-axis shows percent symptom-free from 0 to 100%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.